James L. Gleason
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
James L. Gleason has a total of 97 co-authors. Here are the top co-authors by number of shared publications:
- John Howard White
Department of Physiology, McGill University
6 shared publications Jonathan M. E. Hughes
Department of Chemistry , McGill University , 801 Sherbrooke West , Montreal , QC H3A 2K6 , Canada
5 shared publicationsDainis Kaldre
Department of Chemistry, McGill University, 801 Sherbrooke W., Montreal, QC, H3A 0B8, Canada
4 shared publicationsJames A. Ashenhurst
4 shared publicationsJosephine M. Warnica
Department of Chemistry, McGill University, 801 Sherbrooke W., Montreal, QC, H3A 0B8, Canada
4 shared publicationsAlain Ajamian
Department of Chemistry, McGill University, 801 Sherbrooke Street West, Montreal, QC H3A 2K6, Canada
3 shared publications
Latest Publications
- Open Access
- 16 September 2026
- Published by Georg Thieme Verlag KG in SynOpen
Negative A-Values in Cyclohexanes: Reversal of the Preference for the Equatorial Conformation
This graphical review provides an overview of known exceptions to the general equatorial preference in 6-membered rings. As conformational analysis is critical to catalyst, reaction, and drug design in conformationally flexible systems, understanding exceptions is paramount. Key exceptions to the equatorial preference discussed herein include various forms of the anomeric effect, electrostatic effects like classical and nonclassical hydrogen bonding, hyperconjugation-mediated effects, and strong equatorial gauche interactions including the effect of small spirocycles.
- 16 September 2026
- Published by Georg Thieme Verlag KG in SynOpen
Open AccessNegative A-Values in Cyclohexanes: Reversal of the Preference for the Equatorial Conformation
This graphical review provides an overview of known exceptions to the general equatorial preference in 6-membered rings. As conformational analysis is critical to catalyst, reaction, and drug design in conformationally flexible systems, understanding exceptions is paramount. Key exceptions to the equatorial preference discussed herein include various forms of the anomeric effect, electrostatic effects like classical and nonclassical hydrogen bonding, hyperconjugation-mediated effects, and strong equatorial gauche interactions including the effect of small spirocycles.
- Open Access
- 1 January 2026
- Published by Royal Society of Chemistry (RSC) in Chemical Science
- Vol. 17 (34) , 16339-16345
Metal free [3+2] cycloadditions of alkylidene cyclopropanes via a non-classical “bow-tie” cation
Treatment of cyclopropylidene-containing 1,5-hexadienes with either diazepane carboxylate organocatalysts or Lewis acids initiates a tandem Michael addition – cyclopropane ring-opening (MACRO) sequence resulting in the formation of [3.2.1]-bridged bicycles....
- 1 January 2026
- Published by Royal Society of Chemistry (RSC) in Chemical Science
- Vol. 17 (34) , 16339-16345
Open AccessMetal free [3+2] cycloadditions of alkylidene cyclopropanes via a non-classical “bow-tie” cation
Treatment of cyclopropylidene-containing 1,5-hexadienes with either diazepane carboxylate organocatalysts or Lewis acids initiates a tandem Michael addition – cyclopropane ring-opening (MACRO) sequence resulting in the formation of [3.2.1]-bridged bicycles....
- Open Access
- 18 September 2025
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 68 (19) , 20675-20688
Hyperagonism of a Vitamin D Receptor Agonist/Histone Deacetylase Inhibitor Hybrid Molecule
1,25-Dihydroxyvitamin D (1,25D) analogs engage the vitamin D receptor (VDR) and can exert anticancer and immunomodulatory effects. Although tumors often resist 1,25D monotherapy, combining VDR agonism with histone deacetylase inhibitors (HDACi) restores anticancer efficacy. Here, we present AC-340, a novel bifunctional molecule that incorporates HDACi into a VDR agonist backbone. Besides its robust bifunctionality in vitro in multiple melanoma models, RNaseq analysis of B16–F10 mouse melanoma cells revealed that AC-340 superinduces the expression of a broad array of VDR target genes. Comparative structural studies and ChIP-qPCR revealed that AC-340 forms more interactions than 1,25D with residues in the VDR coactivator binding domain, leading to more efficacious recruitment of coactivator CBP. This, likely coupled with AC-340 HDACi activity, leads to elevated H3K27 acetylation of VDR target genes, a mark of active transcription. Thus, AC-340 functions as a VDR hyperagonist and should be efficacious in mono- or combination therapies against multiple cancer models.
- 18 September 2025
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 68 (19) , 20675-20688
Open AccessHyperagonism of a Vitamin D Receptor Agonist/Histone Deacetylase Inhibitor Hybrid Molecule
1,25-Dihydroxyvitamin D (1,25D) analogs engage the vitamin D receptor (VDR) and can exert anticancer and immunomodulatory effects. Although tumors often resist 1,25D monotherapy, combining VDR agonism with histone deacetylase inhibitors (HDACi) restores anticancer efficacy. Here, we present AC-340, a novel bifunctional molecule that incorporates HDACi into a VDR agonist backbone. Besides its robust bifunctionality in vitro in multiple melanoma models, RNaseq analysis of B16–F10 mouse melanoma cells revealed that AC-340 superinduces the expression of a broad array of VDR target genes. Comparative structural studies and ChIP-qPCR revealed that AC-340 forms more interactions than 1,25D with residues in the VDR coactivator binding domain, leading to more efficacious recruitment of coactivator CBP. This, likely coupled with AC-340 HDACi activity, leads to elevated H3K27 acetylation of VDR target genes, a mark of active transcription. Thus, AC-340 functions as a VDR hyperagonist and should be efficacious in mono- or combination therapies against multiple cancer models.
- Open Access
- 8 October 2024
- Published by Royal Society of Chemistry (RSC) in Chemical Science
- Vol. 15 (44) , 18592-18600
Driving tert-butyl axial: the surprising cyclopropyl effect
The presence of a small spirocyclic ring at an adjacent position alters the conformational preference for equatorial substitution in six-membered rings. DFT calculations and low-temperature 1H NMR experiments demonstrate that alkyl groups larger than methyl possess negative A-values when geminal to a spirocyclopropane, with larger groups such as isopropyl and tert-butyl being exclusively axial at −78 °C. Similar effects are found for heteroatoms, including halogens, and for a range of other electron-withdrawing substituents. Similar effects are observed for other strained rings (epoxide, cyclobutane, oxetane) and the concepts extend to acyclic models as well as heterocycles such as piperidines and piperazines. The origin of the effect is traced to an increase in torsional strain in combination with hyperconjugative effects in the case of electron-poor groups.
- 8 October 2024
- Published by Royal Society of Chemistry (RSC) in Chemical Science
- Vol. 15 (44) , 18592-18600
Open AccessDriving tert-butyl axial: the surprising cyclopropyl effect
The presence of a small spirocyclic ring at an adjacent position alters the conformational preference for equatorial substitution in six-membered rings. DFT calculations and low-temperature 1H NMR experiments demonstrate that alkyl groups larger than methyl possess negative A-values when geminal to a spirocyclopropane, with larger groups such as isopropyl and tert-butyl being exclusively axial at −78 °C. Similar effects are found for heteroatoms, including halogens, and for a range of other electron-withdrawing substituents. Similar effects are observed for other strained rings (epoxide, cyclobutane, oxetane) and the concepts extend to acyclic models as well as heterocycles such as piperidines and piperazines. The origin of the effect is traced to an increase in torsional strain in combination with hyperconjugative effects in the case of electron-poor groups.
- Open Access
- 21 June 2024
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 67 (13) , 11182-11196
Bifunctionality and Antitumor Efficacy of ZG-126, a Vitamin D Receptor Agonist/Histone Deacetylase Inhibitor Hybrid Molecule
Analogues of hormonal vitamin D, 1,25-dihydroxyvitamin D (1,25D), signal through the nuclear vitamin D receptor (VDR). They have potential in combination therapies with other anticancer agents such as histone deacetylase inhibitors (HDACi's). Here, we characterize the ZG series of hybrid compounds that combine HDACi within the backbone of a VDR agonist. All display improved solubility, with ZG-126 being the most robustly bifunctional molecule in multiple cell lines. ZG-126 is well tolerated and strongly induces VDR target gene expression in vivo at therapeutic doses. Its antitumor efficacy is superior to 1,25D and the HDACi SAHA, separately or together, in mouse models of melanoma and triple-negative breast cancer (TNBC). Notably, ZG-126 treatment reduces metastases almost 4-fold in an aggressive TNBC model. ZG-126 also reduces total macrophage infiltration and the proportion of immunosuppressive M2-polarized macrophages in TNBC tumors by 2-fold. ZG-126 thus represents a bifunctional and efficacious anticancer agent with improved physicochemical properties.
- 21 June 2024
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 67 (13) , 11182-11196
Open AccessBifunctionality and Antitumor Efficacy of ZG-126, a Vitamin D Receptor Agonist/Histone Deacetylase Inhibitor Hybrid Molecule
Analogues of hormonal vitamin D, 1,25-dihydroxyvitamin D (1,25D), signal through the nuclear vitamin D receptor (VDR). They have potential in combination therapies with other anticancer agents such as histone deacetylase inhibitors (HDACi's). Here, we characterize the ZG series of hybrid compounds that combine HDACi within the backbone of a VDR agonist. All display improved solubility, with ZG-126 being the most robustly bifunctional molecule in multiple cell lines. ZG-126 is well tolerated and strongly induces VDR target gene expression in vivo at therapeutic doses. Its antitumor efficacy is superior to 1,25D and the HDACi SAHA, separately or together, in mouse models of melanoma and triple-negative breast cancer (TNBC). Notably, ZG-126 treatment reduces metastases almost 4-fold in an aggressive TNBC model. ZG-126 also reduces total macrophage infiltration and the proportion of immunosuppressive M2-polarized macrophages in TNBC tumors by 2-fold. ZG-126 thus represents a bifunctional and efficacious anticancer agent with improved physicochemical properties.
- Open Access
- 24 May 2024
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 274, 116533
Design, synthesis and antiproliferative activity of raloxifene/histone deacetylase inhibitor hybrids in breast cancer
- 24 May 2024
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 274, 116533
Open AccessDesign, synthesis and antiproliferative activity of raloxifene/histone deacetylase inhibitor hybrids in breast cancer
- Open Access
Structural determinants of pure antiestrogenicity
Inhibitory activities of antiestrogens on estrogen receptor alpha (ERα) range from mixed antagonism/agonism (selective ER modulators; SERMs) to complete antiestrogenicity associated with accelerated ERα turnover (selective ER degraders; SERDs). Here, we show using a panel of SERMs, SERDs and a PROTAC that efficient induction of ERα SUMOylation better accounts for complete transcriptional repression than increased suppression of coactivator recruitment or accelerated ERα degradation. Antiestrogen-induced ERα SUMOylation depends on the hydrophobicity of N-terminal residues of ligand binding domain (LBD) helix 12 (H12). L536 mutations, including those occurring in endocrine therapy-resistant breast cancer, abolished SUMOylation with all antiestrogens. Structures of the L536S human ERα LBD bound to fulvestrant analogs and molecular dynamics simulations predict dynamic side chain interactions with wild-type ERα H12 in the coactivator-binding groove and model the impact of L536 mutations. Together, our results show that induced SUMOylation contributes to the complete suppression of ERα activity and provide insights into its structural determinants.
Open AccessStructural determinants of pure antiestrogenicity
Inhibitory activities of antiestrogens on estrogen receptor alpha (ERα) range from mixed antagonism/agonism (selective ER modulators; SERMs) to complete antiestrogenicity associated with accelerated ERα turnover (selective ER degraders; SERDs). Here, we show using a panel of SERMs, SERDs and a PROTAC that efficient induction of ERα SUMOylation better accounts for complete transcriptional repression than increased suppression of coactivator recruitment or accelerated ERα degradation. Antiestrogen-induced ERα SUMOylation depends on the hydrophobicity of N-terminal residues of ligand binding domain (LBD) helix 12 (H12). L536 mutations, including those occurring in endocrine therapy-resistant breast cancer, abolished SUMOylation with all antiestrogens. Structures of the L536S human ERα LBD bound to fulvestrant analogs and molecular dynamics simulations predict dynamic side chain interactions with wild-type ERα H12 in the coactivator-binding groove and model the impact of L536 mutations. Together, our results show that induced SUMOylation contributes to the complete suppression of ERα activity and provide insights into its structural determinants.
- 30 October 2023
- Published by American Chemical Society (ACS) in ACS Chemical Health & Safety
- Vol. 30 (6) , 389-391
Lessons Learned: Spontaneous Detonation of 6-Azidotetrazolo[1,5- b ]pyridazine
We report a case study on the spontaneous detonation of 6-azidotetrazolo[1,5-b]pyridazine, a compound that has been described as being stable despite having an N/C ratio of 2. We share the details of the incident and the lessons learned so that the potential hazards are reported for those who consider its use in the future. The compound was synthesized and handled five times without incident but then detonated upon standing. A one-pot technique to directly convert this hazardous material to the nonenergetic intermediate compound 6-hydroxytetrazolo[1,5-b]pyridazine is also provided.
- 30 October 2023
- Published by American Chemical Society (ACS) in ACS Chemical Health & Safety
- Vol. 30 (6) , 389-391
Lessons Learned: Spontaneous Detonation of 6-Azidotetrazolo[1,5- b ]pyridazine
We report a case study on the spontaneous detonation of 6-azidotetrazolo[1,5-b]pyridazine, a compound that has been described as being stable despite having an N/C ratio of 2. We share the details of the incident and the lessons learned so that the potential hazards are reported for those who consider its use in the future. The compound was synthesized and handled five times without incident but then detonated upon standing. A one-pot technique to directly convert this hazardous material to the nonenergetic intermediate compound 6-hydroxytetrazolo[1,5-b]pyridazine is also provided.
- Open Access
- 17 October 2023
- Published by American Chemical Society (ACS) in ChemRxiv
Driving t-Butyl Axial: The Effect of Small Spirocyclic Rings on A-Values
The presence of a small spirocyclic ring at an adjacent position alters the conformational preference for equatorial substitution in cyclohexane and piperidine rings. DFT and low-temperature 1H NMR experiments demonstrate that alkyl groups larger than methyl possess negative A-values when geminal to a spirocyclohexane. Similar observations are made for halogen and other electron withdrawing substituents. For small groups such as methyl and hydroxy, the A-value is near zero, while for groups such as amino, acetamido and aryl, the A-values are positive, but significantly smaller than for simple cyclohexanes. Similar effects are observed for other strained rings (epoxide, cyclobutane, ox-etane) and the concepts extend to acyclic models. The origin of the effect is traced to an increase in torsional strain in combination with hyperconjugative effects in the case of electron poor groups.
- 17 October 2023
- Published by American Chemical Society (ACS) in ChemRxiv
Open AccessDriving t-Butyl Axial: The Effect of Small Spirocyclic Rings on A-Values
The presence of a small spirocyclic ring at an adjacent position alters the conformational preference for equatorial substitution in cyclohexane and piperidine rings. DFT and low-temperature 1H NMR experiments demonstrate that alkyl groups larger than methyl possess negative A-values when geminal to a spirocyclohexane. Similar observations are made for halogen and other electron withdrawing substituents. For small groups such as methyl and hydroxy, the A-value is near zero, while for groups such as amino, acetamido and aryl, the A-values are positive, but significantly smaller than for simple cyclohexanes. Similar effects are observed for other strained rings (epoxide, cyclobutane, ox-etane) and the concepts extend to acyclic models. The origin of the effect is traced to an increase in torsional strain in combination with hyperconjugative effects in the case of electron poor groups.
- 3 August 2023
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 59 (70) , 10496-10499
Mimicking enzymatic cation–π interactions in hydrazide catalyst design: access to trans-decalin frameworks
Terphenyl hydrazide catalysts simultaneously activate enals towards polyene cyclization and stabilize intermediates by cation–π interactions to provide trans-decalins in high enantioselectivity.
- 3 August 2023
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 59 (70) , 10496-10499
Mimicking enzymatic cation–π interactions in hydrazide catalyst design: access to trans-decalin frameworks
Terphenyl hydrazide catalysts simultaneously activate enals towards polyene cyclization and stabilize intermediates by cation–π interactions to provide trans-decalins in high enantioselectivity.